eriocitrin has been researched along with Adenocarcinoma of Lung in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, Y; Gao, M; Geng, Q; Lai, K; Li, N; Lu, Z; Song, C; Wang, W; Xu, C | 1 |
1 other study(ies) available for eriocitrin and Adenocarcinoma of Lung
| Article | Year |
|---|---|
Eriocitrin inhibits epithelial-mesenchymal transformation (EMT) in lung adenocarcinoma cells via triggering ferroptosis.
Topics: Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Ferroptosis; Humans; Iron; Lung Neoplasms; Neoplasm Recurrence, Local; Reactive Oxygen Species | 2023 |